Evidence map›Paper›PMID 29178486›Full record

ArticleMedical physics2018

Developing and characterizing MR/CT-visible materials used in QA phantoms for MRgRT systems.

Angela Steinmann, R Jason Stafford, Gabriel Sawakuchi, Zhifei Wen, Laurence Court, Clifton D Fuller, David Followill

Open access · greenAbstract read
In one paragraph

Article in Medical physics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Medical physics challenges in clinical MR-guided radiotherapy.Radiation oncology (London, England) · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. The role of dosimetry audit in achieving high quality radiotherapy.Physics and imaging in radiation oncology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Angela SteinmannDepartment of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA.
R Jason StaffordDepartment of Imaging Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA.
Gabriel SawakuchiDepartment of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA.
Zhifei WenDepartment of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA.
Laurence CourtDepartment of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA.
Clifton D FullerDepartment of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA.
David FollowillDepartment of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
imaging Radiation-Associated Dysphagia (iRAD)R01CA218148 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FULLER, CLIFTON DAVID, HUTCHESON, KATHERINE ARNOLD · 2017 to 2019
$810k
NCI NIH HHS R01 CA218148NCI NIH HHS U24 CA180803
6 · The paper itself

Abstract

purposeSynthetic tissue equivalent (STE) materials currently used to simulate tumor and surrounding tissues for IROC-Houston's anthropomorphic head and thorax QA phantoms cannot be visualized using magnetic resonance (MR) imaging. The purpose of this study was to characterize dual MR/CT-visible STE materials that can be used in an end-to-end QA phantom for MR-guided radiotherapy (MRgRT) modalities.

methodsOver 80 materials' MR, CT, and dosimetric STE properties were investigated for use in MRgRT QA phantoms. The materials tested included homogeneous and heterogeneous materials to simulate soft tissue/tumor and lung tissues. Materials were scanned on a Siemens' Magnetom Espree 1.5 T using four sequences, which showed the materials visual contrast between T1- and T2-weighted images. Each material's Hounsfield number and electron density data was collected using a GE's CT Lightspeed Simulator. Dosimetric properties were examined by constructing a 10 × 10 × 20 cm

resultsThe majority of the tested materials showed comparable CT attenuation properties to their respective organ site; however, most of the tested materials were not visible on either T1- or T2-weighted MR images. Silicone, hydrocarbon, synthetic gelatin, and liquid PVC plastic-based materials showed good MR image contrast. In-house lung equivalent materials made with either silicone- or hydrocarbon-based materials had HUs ranging from: -978 to -117 and -667 to -593, respectively. Synthetic gelatin and PVC plastic-based materials resembled soft tissue/tumor equivalent materials and had HUs of: -175 to -170 and -29 to 32, respectively. PDD curves of the selected MR/CT-visible materials were comparable to IROC-Houston's conventional phantom STE materials. The smallest field size showed the largest disagreements, where the average discrepancies between calculated and measured PDD curves were 1.8% and 5.9% for homogeneous and heterogeneous testing materials, respectively.

conclusionsGelatin, liquid plastic, and hydrocarbon-based materials were determined as alternative STE substitutes for MRgRT QA phantoms.

Indexed as

Phantoms, ImagingMagnetic Resonance ImagingQuality ControlRadiometryRadiotherapy, Image-GuidedThoraxTomography, X-Ray Computedanthropomorphic QA phantomsMRgRTMRI -guided radiotherapy

Identifiers

PMID29178486
PMCPMC5807190
OpenAlexW2768149317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.